TGF-β inhibition can overcome cancer primary resistance to PD-1 blockade: A mathematical model.
Immune checkpoint inhibitors have demonstrated, over the recent years, impressive clinical response in cancer patients, but some patients do not respond at all to checkpoint blockade, exhibiting primary resistance. Primary resistance to PD-1 blockade is reported to occur under conditions of immunosu...
Saved in:
Main Authors: | Nourridine Siewe, Avner Friedman |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/7dca81abbfbf4d83b65009791af3b7f8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer
by: Grégoire de Streel, et al.
Published: (2020) -
TNFα blockade overcomes resistance to anti-PD-1 in experimental melanoma
by: Florie Bertrand, et al.
Published: (2017) -
Lin−CCR2+ hematopoietic stem and progenitor cells overcome resistance to PD-1 blockade
by: Catherine T. Flores, et al.
Published: (2018) -
Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance
by: Yong Liang, et al.
Published: (2018) -
Correction: Dual PD-L1 and TGF-b blockade in patients with recurrent respiratory papillomatosis
Published: (2021)